SGS Introduces US Food and Drug Administration New Standards for Infant Formula

On 10 February 2014 the United States Food and Drug Administration (US FDA) published their interim final rule on Current Good Manufacturing Practices (cGMPs), Quality Factors, Notification Requirements, and Records and Reports, for Infant Formula (1).

Fairfield, NJ, March 14, 2014 --( This interim final rule implements the remaining provisions of the 1986 Anti-Drug Abuse Act which amended Section 412 of the Food Drug and Cosmetic Act (FDC&A). Section 412 of the FDC&A was created by the Infant Formula Act of 1980. Exempt from this rule will be formulas made for infants with unusual medical and dietary problems such as formulas for infants born extremely pre-mature.

Current Good Manufacturing Practices and Quality Control Procedures to Prevent Adulteration of Infant Formula

- One of the cGMPs being required is controls to prevent adulteration by contamination of infant formula from microorganisms requiring testing of powdered infant formula at the final stage for Cronobacter and Salmonella species. Other requirements involve a code that identifies the location of packing and tracing of all stages of the manufacturing process, approved release of finished products and controls to prevent adulteration by contamination during manufacturing or packing from many sources.
- Quality control procedures are revised to require in-process and final product testing to ensure that all required and added nutrients are present and at appropriate levels. For example, the finished product, before distribution shall be tested for vitamin A, C, E and thiamin.
- Requirements to conduct regularly scheduled audits to determine cGMP and quality control procedure compliance are established.
- The US FDA established two quality factors, the manufacturer is to conduct a growth monitoring study of the formula and conduct a Protein Efficiency Ratio rat bioassay to establish biological protein quality.
- There is a registration requirement to provide the US FDA information about the firms producing infant formulas for US distribution. Requirements to provide scientific data and information to the US FDA to demonstrate a new infant formula contains all the required nutrients and meets or the requirements of the rule.
- Records and report requirements are included to support the requirements as listed in this rule such as the microbiological testing requirements.

Comments may be submitted until 27 March 2014 and this rule will become effective 10 July 2014.

(1) Current Good Manufacturing Practices, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports, for Infant Formula (

About SGS Food Safety Services
SGS is committed to keeping readers informed of regulatory news and developments. Leveraging a global network of laboratories and food experts, SGS provides a comprehensive range of food safety and quality solutions including analytical testing (, audits, certifications, inspections and technical support. SGS continually invests in world class testing capabilities and state-of-the-art technology to help clients reduce risks, and improve food safety and quality.

For further information please contact the SGS food experts.

Contact details:
SGS Consumer Testing Services
James Cook
Food Safety Technologist
291 Fairfield Ave, Fairfield
New Jersey 07004, USA

t +1 973 461 1493

SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 80,000 employees, SGS operates a network of over 1,650 offices and laboratories around the world.
SGS Consumer Testing Services
James Cook
+1 973 461 1493
291 Fairfield Ave, Fairfield
New Jersey 07004, USA